Consumer Protection Act 2019 — Key Changes Every Doctor and Hospital Must Know

For three decades, the Consumer Protection Act 1986 governed the relationship between patients and healthcare providers in India. It gave patients a relatively accessible forum — the consumer commission — to seek compensation for medical negligence without the cost and delay of civil litigation. Then, in July 2020, the Consumer Protection Act 2019 came into force, replacing the 1986 Act entirely.

The changes were not cosmetic. The 2019 Act introduced new pecuniary jurisdictional limits, mandatory mediation, an online filing portal, a new regulatory authority, product liability provisions, and enhanced compensation powers. For every doctor, hospital, clinic, and healthcare institution in India, understanding these changes is no longer optional — it is a compliance imperative.

"The Consumer Protection Act 2019 has significantly expanded the tools available to patients filing complaints against healthcare providers. The introduction of mandatory mediation, e-filing, and product liability provisions means that both the volume and the nature of healthcare complaints before consumer forums will change. Hospitals and clinicians who are not aware of these changes are already behind."
— Dr. Namit Gupta, Senior Medico-Legal Expert

1. Overview: Why the 2019 Act Matters to Healthcare

The Consumer Protection Act 2019 was notified and brought into force on 20 July 2020 by the Ministry of Consumer Affairs. It replaced the Consumer Protection Act 1986 in its entirety. The legislative intent was to modernise consumer protection law for a digital era, strengthen enforcement, create a dedicated regulatory body, and introduce product liability as a distinct legal concept.

Healthcare services have long been held to fall within the definition of "services" under consumer law — a position firmly established by the Supreme Court in Indian Medical Association v. V.P. Shantha (1995). The 2019 Act does not disturb that position. Medical services rendered for consideration (payment) — whether by private hospitals, nursing homes, clinics, or doctors — remain fully subject to consumer law. What has changed is the procedural and substantive framework within which complaints are heard and decided.

Every doctor, hospital, and healthcare institution in India should read the 2019 Act as both a risk and an opportunity. A risk, because more accessible filing and stronger enforcement means more complaints. An opportunity, because mediation — a new mandatory step — allows for earlier, quieter resolution of disputes before they become public legal proceedings.

2. New Pecuniary Limits: More Cases at the District Level

One of the most practically significant changes in the 2019 Act is the revision of pecuniary (monetary) jurisdictional limits — determining which tier of consumer commission hears a complaint based on the amount claimed.

The practical consequence of this revision is profound. The vast majority of medical negligence complaints — including most claims arising from surgical errors, delayed diagnosis, birth injuries, and ICU deaths — will now fall within the jurisdiction of the District Consumer Commission rather than the State Commission. This means:

• Faster hearings — District Commissions generally have shorter queues than State Commissions
• Easier access for patients — filing is in the patient's own district of residence or the hospital's location
• Higher volume of complaints at the district level — hospitals must be prepared for increased litigation at this tier

For context, under the 1986 Act, a claim for ₹50 lakh would have gone directly to the State Commission. Under the 2019 Act, that same claim stays at the District Commission — closer to the patient, with a potentially shorter timeline to resolution.

3. E-Filing and the Central Consumer Protection Authority (CCPA)

The Consumer Protection Act 2019 introduced two entirely new features that have no parallel in the 1986 Act: electronic filing of complaints and a national-level regulatory authority.

E-Filing: The e-Daakhil Portal

Section 35 of the 2019 Act explicitly permits filing of consumer complaints electronically. The e-Daakhil portal (edaakhil.nic.in) operationalises this provision, allowing a patient anywhere in India to file a complaint, upload documents, pay the filing fee online, and track case progress — without setting foot in a consumer commission office. For medical negligence cases, this means:

• A patient in Raipur can file against a hospital in Delhi
• Documents such as hospital records, discharge summaries, and expert opinions can be uploaded digitally
• The barrier of geography has been substantially reduced

For hospitals, this translates directly into higher volume of complaints and a need for robust internal documentation systems that can respond to consumer commission notices quickly.

The Central Consumer Protection Authority (CCPA)

The CCPA is an entirely new institution created under Chapter III of the 2019 Act. It is a national-level regulatory body with wide-ranging powers:

• Suo motu powers: The CCPA can investigate consumer rights violations on its own initiative — without waiting for an individual complaint. If a pattern of negligence at a hospital chain comes to the CCPA's attention (through media reports, NGO complaints, or data from commissions), it can investigate independently.
• Class action investigations: The CCPA can direct investigations affecting a large number of consumers — relevant for systemic failures in healthcare (e.g., a blood bank selling contaminated blood, a hospital implanting recalled devices).
• Misleading advertisements: The CCPA has explicit jurisdiction over misleading health advertisements — hospitals and diagnostic centres making false claims about success rates, survival rates, or treatment outcomes can be investigated and penalised.
• Penalties: The CCPA can impose penalties and recommend remediation across sectors, including healthcare.

4. Mediation: Section 37 and the Mediation Cells

This is perhaps the most significant procedural change for medical negligence practitioners. Section 37 of the Consumer Protection Act 2019 mandates that at the first hearing of a consumer complaint, if the commission is of the opinion that there is a chance of settlement, it shall direct the parties to the Mediation Cell attached to that commission.

Key features of the mediation framework:

• Mediation Cells are now attached to each District, State, and National Consumer Commission
• Mediation is conducted by trained mediators, not judges
• The process is time-bound — mediation must be completed within a prescribed period (typically a few months)
• If settlement is reached, the commission passes an order in terms of the settlement — which is as binding as any commission award
• If mediation fails, the case returns to the commission for full adjudication — the mediation proceedings are confidential and cannot be used as evidence

For medical negligence cases, this means that the vast majority of complaints will now go through a mandatory mediation attempt first. This is a significant opportunity for hospitals and doctors. Settlement through mediation is:

• Confidential — there is no public record of an adverse order
• Faster — far quicker than waiting for full adjudication
• Controllable — the quantum of settlement is negotiated, not imposed
• Reputation-protecting — avoids the stigma of a consumer commission judgment finding negligence

Hospitals with active medico-legal risk management programmes will use this provision strategically.

5. Product Liability: Chapter VI — A New Exposure for Healthcare

Chapter VI of the Consumer Protection Act 2019 introduces product liability as a distinct legal concept in Indian consumer law — there was no equivalent provision in the 1986 Act. Product liability under Section 84–87 imposes strict liability on product manufacturers, product service providers, and product sellers for harm caused by defective products or deficient services.

The healthcare relevance of this chapter is significant and multi-layered:

Pharmaceutical Companies

A pharmaceutical company that manufactures a drug with a defect — whether in formulation, manufacturing, or labelling — can now face direct product liability under the CPA 2019 in addition to existing liability under the Drugs and Cosmetics Act 1940.

Medical Device Manufacturers

Manufacturers of surgical implants, cardiac stents, orthopaedic devices, pacemakers, or diagnostic equipment are exposed to product liability claims if a device causes harm due to a manufacturing defect or design flaw. This is particularly relevant given India's growing medical device sector and the increasing use of foreign-manufactured devices.

Hospital Pharmacy Dispensing Defective Drugs

A hospital pharmacy that dispenses a defective or counterfeit drug — even if the pharmacy itself did not manufacture it — may face product liability as a "product seller" under Section 87 of the Act if it did not exercise due care in the selection and storage of the product.

AI Diagnostic Tools and Software

The 2019 Act's product liability framework is future-oriented. AI-based diagnostic software used in hospitals — image analysis tools, ECG interpretation software, pathology AI — if found to have a defect that causes patient harm, could potentially attract product liability against the manufacturer. This is an emerging area that has not yet been tested in Indian courts but is directly within the scope of Chapter VI.

6. Service Deficiency in Healthcare: Section 2(11) CPA 2019

Section 2(11) of the Consumer Protection Act 2019 defines "deficiency" as any fault, imperfection, shortcoming, or inadequacy in the quality, nature, and manner of performance required to be maintained in relation to any service. In the healthcare context, this translates to the Bolam standard as applied by consumer forums:

A doctor or hospital is liable for service deficiency if their conduct fell below the standard of care expected of a reasonably competent medical professional in that specialty — as established in Jacob Mathew v. State of Punjab (2005) and subsequent Supreme Court decisions. Consumer forums do not require proof of criminal intent or gross recklessness — mere failure to meet the standard of a reasonably competent practitioner is sufficient to establish deficiency of service and attract compensation.

The standard is objective. Courts ask: would a reasonably competent doctor in the same specialty, given the same clinical information, have acted as this doctor acted? If the answer is no, there is deficiency of service under the CPA 2019.

7. Free Medical Treatment: Not a "Service" Under CPA 2019

The position established under the 1986 Act — and consistently upheld by the Supreme Court — is preserved under the 2019 Act. Services rendered free of charge are not "services" within the meaning of the Act. A patient who receives entirely free treatment at a government hospital — where no fee whatsoever is charged — cannot file a consumer complaint for negligence in that treatment.

However, the boundary is narrow. If a government hospital charges even a nominal registration fee, consultation fee, or procedure charge, that element of paid service is covered. Patients in Ayushman Bharat schemes present a nuanced question that courts are still working through — whether insurance-funded treatment constitutes payment by the patient such that it falls within the Act's scope.

8. Referral Fees, Kickbacks and Unfair Trade Practices

The Consumer Protection Act 2019 explicitly covers "unfair trade practices" — defined broadly to include misleading advertisements, false guarantees, and other deceptive commercial conduct. Read with the NMC (National Medical Commission) regulations on professional conduct, the 2019 Act creates a new exposure for doctors who accept referral fees or kickbacks from diagnostic centres, pharmaceutical companies, or other hospitals.

A doctor who accepts payment for referring patients to a specific diagnostic centre or hospital — and does not disclose this financial relationship — may be engaging in an unfair trade practice under CPA 2019, exposing themselves to both consumer complaints and NMC disciplinary action. This is a compliance area that many private practitioners have not yet adequately addressed.

9. Enhanced Compensation: Section 39 and Punitive Damages

Section 39 of the Consumer Protection Act 2019 empowers consumer commissions to award compensation including punitive damages in cases of gross negligence. The 2019 Act places no upper cap on compensation that the National Consumer Commission can award. For particularly egregious cases — a surgeon operating on the wrong patient, a hospital concealing evidence of negligence, a clinic reusing single-use consumables — punitive damages are now an explicit tool available to consumer commissions.

Compensation can include:

• Medical expenses past and future
• Loss of income and earning capacity
• Pain, suffering and mental agony
• Cost of corrective treatment
• Litigation costs
• Punitive damages in gross negligence cases

10. Class Action and Group Complaints: Section 35(1)(c)

The Consumer Protection Act 2019 significantly strengthens the ability of patient groups and consumer organisations to file collective complaints. Under Section 35(1)(c), a complaint can be filed by:

• A recognised consumer association (whether or not its members are personally affected)
• One or more consumers on behalf of numerous consumers having the same interest
• The Central Government, State Government, or a Union Territory

This is directly applicable to healthcare scenarios where a systemic failure has harmed multiple patients — contaminated dialysis water, mass infection from unsterile surgical instruments, fraudulent billing schemes. Such collective complaints, even if each individual claim is modest, can be filed as a single representative action, dramatically increasing the reputational and financial stakes for a hospital or health system.

11. Comparison: CPA 1986 vs CPA 2019 for Healthcare

Conclusion

The Consumer Protection Act 2019 represents the most significant overhaul of consumer protection law in India in three decades, and healthcare is among the sectors most directly affected. The combination of higher jurisdictional limits at the district level (meaning more cases stay local and move faster), e-filing (meaning more cases are filed), mandatory mediation (meaning disputes can and should be resolved earlier), product liability (meaning the hospital-as-institution faces new exposure), and the CCPA's suo motu powers (meaning systemic failures attract regulatory scrutiny) creates a fundamentally changed legal landscape for healthcare providers.

Hospitals and clinicians who engage proactively with this framework — through comprehensive consent documentation, rigorous incident review, trained medico-legal response teams, and strategic use of the mediation window — will be far better positioned than those who encounter it for the first time when a consumer notice arrives.

If your hospital or clinic has received a notice from a consumer commission, or if you are reviewing your institution's medico-legal compliance posture, contact our team for an expert assessment and representation.